The role of radiotherapy in the treatment of oligometastatic non-small cell lung cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F25%3A10500653" target="_blank" >RIV/00669806:_____/25:10500653 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11140/25:10500653
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=FkV67Dij5R" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=FkV67Dij5R</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5603/rpor.107745" target="_blank" >10.5603/rpor.107745</a>
Alternative languages
Result language
angličtina
Original language name
The role of radiotherapy in the treatment of oligometastatic non-small cell lung cancer
Original language description
In the recent years, the clinical stage where the cancer has spread beyond the primary site, but has not yet metastasised extensively, and which is known as oligometastatic disease (OMD), has become an object of interest to radiation oncologists. OMD is a kind of an "umbrella term" for a variety of clinical situations.This review focuses on the role of radiotherapy (RT) in the treatment of oligometastatic non-small cell lung cancer (OM-NSCLC). Currently, a wide range of techniques and fractionation regimens are used to treat OM-NSCLC and, unfortunately, it is not yet possible to determine which approach is the most effective. Therefore, more than ever, we should use the concept of risk-adapted RT and consider many factors when choosing the fractionation regimen and total dose applied. For different clinical scenarios, we set different treatment goals and derive different RT techniques and fractionations.Oligoprogression (OP) is a specific type of OMD that is increasingly encountered in clinical situations, probably due to the increased use of targeted therapy and the subsequent acquired resistance of a certain subpopulation of tumour cells. OP is the progression of a limited number of metastases after an initial response to systemic therapy. The rationale for using RT in areas of progression is to overcome tumour resistance in these progressive lesions.A number of trials are currently underway to find the optimal RT techniques for the most appropriate patients at a precise clinical stage.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Reports of Practical Oncology and Radiotherapy
ISSN
1507-1367
e-ISSN
2083-4640
Volume of the periodical
30
Issue of the periodical within the volume
3
Country of publishing house
PL - POLAND
Number of pages
11
Pages from-to
385-395
UT code for WoS article
001563418900001
EID of the result in the Scopus database
2-s2.0-105022199841